Post job

Valencell main competitors are Google, Ambarella, and Intuitive Surgical.

Competitor Summary. See how Valencell compares to its main competitors:

  • Google has the most employees (139,995).
  • Employees at Google earn more than most of the competitors, with an average yearly salary of $140,774.
  • The oldest company is Johnson & Johnson, founded in 1886.
Work at Valencell?
Share your experience

Valencell vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
2006
4.1
Raleigh, NC1$6.8M35
1961
4.5
San Antonio, TX6$220.0M1,800
1995
4.7
Santa Clara, CA4$1.4B2,200
1998
4.8
Mountain View, CA32$350.0B139,995
1886
4.7
New Brunswick, NJ26$88.8B134,500
1891
4.6
Kenilworth, NJ31$64.2B74,000
1996
4.7
New York, NY3$705.0M1,800
2004
4.3
Santa Clara, CA1$284.9M750
1989
4.0
Chandler, AZ12$7.6B19,500
1995
4.9
Sunnyvale, CA2$8.4B5,527
1997
3.5
Rochester, NY2$12.1M90
FDD
2001
4.4
Washington, DC1$9.0M7
1961
3.9
Washington, DC1$19.6M2,016
Morphogenesis
1995
3.7
Tampa, FL1$510,0007
1955
3.6
Philadelphia, PA1$2.0M50
1962
4.4
Washington, DC1$50.6M350
1984
4.6
Mountain View, CA1$20.3M100
1961
4.1
New York, NY1$30.1M29

Rate how well Valencell differentiates itself from its competitors.

Zippia waving zebra

Valencell salaries vs competitors

Among Valencell competitors, employees at Google earn the most with an average yearly salary of $140,774.

Compare Valencell salaries vs competitors

CompanyAverage salaryHourly salarySalary score
Valencell
$67,029$32.23-
Frost & Sullivan
$72,813$35.01-
OmniVision Technologies
$107,801$51.83-
Google
$140,774$67.68-
Johnson & Johnson
$76,686$36.87-
Merck
$90,328$43.43-

Compare Valencell job title salaries vs competitors

CompanyHighest salaryHourly salary
Valencell
$99,413$47.79
Google
$131,027$62.99
Intuitive Surgical
$106,188$51.05
OmniVision Technologies
$105,876$50.90
Ambarella
$101,940$49.01
Vuzix
$99,996$48.08
Merck
$88,869$42.73
WebMD
$88,273$42.44
CSIS
$77,021$37.03
Frost & Sullivan
$77,010$37.02
World Policy Journal
$73,732$35.45
Morphogenesis
$73,051$35.12
FDD
$72,895$35.05
Foreign Policy Research Institute
$68,204$32.79
SETI Institute
$67,724$32.56
Microchip Technology
$64,661$31.09
Johnson & Johnson
$64,371$30.95
Hudson Institute
$64,111$30.82

Do you work at Valencell?

Does Valencell effectively differentiate itself from competitors?

Valencell jobs

Valencell demographics vs competitors

Compare gender at Valencell vs competitors

Job titleMaleFemale
Merck54%46%
Johnson & Johnson58%42%
Intuitive Surgical63%37%
Microchip Technology70%30%
Vuzix89%11%
Valencell--
Male
Female

Compare race at Valencell vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
43%24%7%22%4%
9.8
54%16%10%15%4%
9.8
56%16%10%14%4%
9.8
55%20%5%15%5%
9.9
68%12%14%4%3%
4.7
50%18%9%18%5%
9.6

Valencell and similar companies CEOs

CEOBio
Fermi Wang
Ambarella

Fermi Wang is a seasoned leader, a serial entrepreneur, and a video compression technology expert. He holds several digital video-related patents, including one of MPEGLA's core MPEG-2 and MPEG-4/AVC patents. Prior to Ambarella, Wang was CEO and co-founder of Afara Websystems, which pioneered server throughput computing. Afara was acquired by Sun Microsystems in July 2002. Afara's multi-core, multi-thread CPU is the critical technology in Sun’s UltraSPARC roadmap. Before founding Afara, Wang served in senior engineering and business management roles at C-Cube Microsystems. Wang's team was responsible for developing the world’s first MPEG CODEC chip.

Gary S. Guthart
Intuitive Surgical

Gary Guthart joined Intuitive Surgical in April 1996. Effective January 2010, Guthart was appointed as Chief Executive Officer. In July 2007, he was promoted to President. Prior to that, in February 2006, Guthart assumed the role of Chief Operating Officer. Prior to joining Intuitive, Guthart was part of the core team developing foundation technology for computer enhanced-surgery at SRI International (formerly Stanford Research Institute). Guthart is currently a member of the Board of Directors of Affymetrix, Inc. He received a B.S. in Engineering from the University of California, Berkeley and an M.S. and a Ph.D. in Engineering Science from the California Institute of Technology.

Joaquin Duato
Johnson & Johnson

Robert M. Davis
Merck

Robert M. Davis is corporate vice president and president of Baxter's Medical Products business. In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took on his current role in October 2010. Prior to this role, Davis served as corporate vice president and president of Baxter's Renal business. He served as corporate vice president and chief financial officer from 2006 through May 2010, and as treasurer from 2004 through 2006. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served in numerous positions of increasing responsibility over 14 years. Davis currently serves on the Board of Trustees for Rush University Medical Center and also serves as a member of the Finance Committee. He also is a member of the Board of Directors of AdvaMed.

Paul J. Travers
Vuzix

Mr. Paul Travers J. is a Chief Executive Officer at VUZIX CORP and is based in United States.

Darrell Huntsman
Frost & Sullivan

Darrell's passion is creating and building mission driven businesses. He sees technology and education as the fulcrum which human experiences, businesses, and communities can become better. As a driven and tireless leader, he believes that values and a compelling vision steeped in relentless execution will lead to achievement and happiness. Some of Darrell's favorite quotes are: \'Try not to become a man of success. Rather become a man of value.\' -- Albert Einstein \'It is only through labor and painful effort, by grim energy and resolute courage, that we move on to better things.\' -- Theodore Roosevelt \'Happiness is something final and complete in itself, As being the aim and end of practical activities whatever... Happiness then we define as the active exercise of the mind In conformity with perfect goodness or virtue\' -- Aristotle \'Customers will never love a company until the employees love it first” -- Simon Sinek In addition to being a successful entrepreneur, Darrell served in various executive leadership and general management roles with P&L responsibilities of over $300M in revenue and staff of 180 people for 10 years at Reed Elsevier RELX (LexisNexis), a $9.5 billion information services company. Prior to Reed Elsevier, he worked at Bain & Company. He engaged on strategy and operational improvement efforts with companies in software, manufacturing, retail and services. He also loved his 3 years with 3M Company (NYSE: MMM) in its prestigious Optimized Operations program working as a chemical engineer and manufacturing engineer on manufacturing improvement projects across the globe. Darrell holds a Bachelor of Science degree in Chemical Engineering from Brigham Young University and an M.B.A. from Harvard Business School.

Sundar Pichai
Google

Robert Brisco
WebMD

Bob Brisco is a Chief Executive Officer at WEBMD HEALTH CORP. and Founder at Classified Ventures and is based in Los Angeles, California. He has worked as President at Universal Citywalk Hollywood, President/CEO at Internet Brands, and President at Universal Studios Hollywood. Robert studied at University of Southern California between 1980 and 1984; University of California, Los Angeles between 1985 and 1987; and UCLA Anderson School of Management between 1985 and 1987.

John P. Walters
Hudson Institute

As Chief Operating Officer, John Walters oversees the Hudson Institute's operations, including staff and research management. From December 2001 to January 2009, he was director of the White House Office of National Drug Control Policy (ONDCP) and a cabinet member during the Bush Administration. As the nation's ''Drug Czar,'' Mr. Walters guided all aspects of federal drug policy and programs—supporting efforts that drove down teen drug use 25 percent, increased substance abuse treatment and screening in the healthcare system and dramatically dropped the availability of cocaine and methamphetamine in the U.S. He also helped build critical programs to counter narcoterrorism in Colombia, Mexico, and Afghanistan.

Valencell competitors FAQs

Search for jobs